Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6565717 | 0.77 | THRB (0.35) | THRBLMNA | |
| SCHEMBL12997251 | 0.75 | THRB (0.33) | THRBLMNA | |
| SCHEMBL11498597 | 0.73 | THRB (0.32) | THRBLMNA | |
| SCHEMBL854693 | 0.71 | THRB (0.44) | THRBLMNA | |
| SCHEMBL17188513 | 0.70 | — | — | |
| SCHEMBL277640 | 0.69 | THRB (0.42) | THRBLMNA | |
| SCHEMBL8315999 | 0.69 | THRB (0.42) | THRBLMNA | |
| SCHEMBL2332578 | 0.69 | THRB (0.42) | THRBLMNA | |
| SCHEMBL9695937 | 0.67 | THRB (0.40) | THRBLMNA | |
| SCHEMBL853104 | 0.67 | THRB (0.40) | THRBLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20130230898-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-20130230898-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-09-05 | — | — | US | disclosed |
| US-8404834-B2 | Hydroxyalkyl starch derivatives and process for their preparation | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-03-26 | — | — | US | disclosed |
| US-8404834-B2 | Hydroxyalkyl starch derivatives and process for their preparation | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2013-03-26 | — | — | US | disclosed |
| EP-2231711-B1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DE GMBH (DE) | 2012-11-07 | — | — | EP | disclosed |
| US-20100305033-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2010-12-02 | — | — | US | disclosed |
| US-20100305033-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2010-12-02 | — | — | US | disclosed |
| WO-2009077154-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | FRESENIUS KABI DEUTSCHLAND GMBH (DE) | 2009-06-25 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100305033-A1 | HYDROXYALKYL STARCH DERIVATIVES AND PROCESS FOR THEIR PREPARATION | HDHD5, KHK, SORD | THRB 4854/4885LMNA 1787/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.